Possible involvement of enhanced arginase activity due to up-regulated arginases and decreased hydroxyarginine in accelerating intimal hyperplasia with hyperglycemia

Vascular Pharmacology

Volumn 47, Issue 5-6, 2007, Pages 272-280

  Ishizaka, Mihoko ^a   Nagai, Akiko ^a   Iwanaga, Mioko ^a   Imamura, Masatoshi ^a   Azuma, Hiroshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Arginase I and II; DDAH; Endogenous NOS inhibitors; Hydroxyarginine; Hyperglycemia; Intimal hyperplasia

Indexed keywords

ALLOXAN; ARGINASE; ARGININE DERIVATIVE; HYDROXYARGININE; MONOMETHYLARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYPERGLYCEMIA; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ALLOXAN; AMIDOHYDROLASES; ANIMALS; AORTA, THORACIC; ARGINASE; ARGININE; BLOOD GLUCOSE; CAROTID ARTERIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC GMP; ENDOTHELIAL CELLS; HYPERGLYCEMIA; HYPERPLASIA; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RABBITS; TUNICA INTIMA; UP-REGULATION;

EID: 35549002573     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.08.001     Document Type: Article

References (35)

1. Alipui C., Tenner T.E., and Ramos K. Rabbit aortic smooth muscle cell culture. A model for the pharmacological study of diabetes-induced alterations in cell proliferation. J. Pharmacol. Methods 26 (1991) 211-222
2. Azuma H., Ishikawa M., and Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br. J. Pharmacol. 88 (1986) 441-445
3. Azuma H., Niimi Y., and Hamasaki H. Prevention of intimal hyperplasia after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. Br. J. Pharmacol. 106 (1992) 665-671
4. Azuma H., Hamasaki H., Niimi Y., Terada T., and Matsubara O. Role of endothelin-1 in neointima formation after endothelial removal in rabbit carotid arteries. Am. J. Physiol., Heart Circ. Physiol. 267 (1994) H2259-H2267
5. Azuma H., Sato J., Hamasaki H., Sugimoto A., Isotani E., and Obayashi S. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of l-arginine in regenerated endothelial cells. Br. J. Pharmacol. 115 (1995) 1001-1004
6. Beppu M., Obayashi S., Aso T., Goto M., and Azuma H. Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall and intimal hyperplasia in perimenopausal human uterine arteries. J. Cardiovasc. Pharmacol. 39 (2002) 192-200
7. Blantz R.C., Satriano J., Gabbai F., and Kelly C. Biological effects of arginine metabolites. Acta Physiol. Scand. 168 (2000) 21-25
8. Bode-Boger S., Boger R.F., Kienk S., Junker W., and Florich J.C. Elevated l-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary l-arginine in hypercholesterolemic rabbits. Biochem. Biophys. Res. Commun. 219 (1996) 598-603
9. Boger R.H., and Bode-Boger S.M. The clinical pharmacology of l-arginine. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 79-99
10. Boger R.H., Bode-Boger S.M., Szuba A., Tsao P.S., Chan J.R., Tongphao T.F., and Cooke J.P. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 (1998) 1842-1847
11. G-hydroxy-l-arginine, an intermediate in the l-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res. Commun. 203 (1994) 1614-1621
12. Boulanger C., and Lüscher T.H. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85 (1990) 587-590
13. G-hydroxy l-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem. Biophys. Res. Commun. 202 (1994) 174-180
14. Furchgott R.F. Role of endothelium in responses of vascular smooth muscle. Circ. Res. 53 (1983) 557-573
15. Goto M., Yamauchi Y., Kurosaki E., and Azuma H. Possible involvement of facilitated polyol pathway in augmentation of intimal hyperplasia in rabbits with alloxan-induced hyperglycemia. J. Cardiovasc. Pharmacol. 41 (2003) 265-275
16. Hamasaki H., Sato J., Masuda H., Tamaoki S., Isotani E., Obayashi S., Udagawa T., and Azuma H. Effect of nicotine in the intimal hyperplasia after endothelial removal of the rabbit carotid artery. Gen. Pharmacol. 28 (1997) 653-659
17. Hirata M., Obayashi S., Sakamoto S., Aso T., Imamura M., and Azuma H. Involvement of arginase in regulating myometrial contractions during gestation in the rat. Mol. Hum. Reprod. 12 (2006) 513-518
18. Ignarro L., Buga G.M., Wei L.-H., Bauer P.M., and Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4202-4208
19. Jenkinson C.P., Grody W.W., and Cederbaum S.D. Comparative properties of arginases. Comp. Biochem. Physiol., Part B Biochem. Mol. Biol. 114 (1996) 107-132
20. Lefer A.M. Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation 95 (1997) 553-554
21. Lin K.Y., Ito A., Asagami T., Tsao P.S., Adimoolam S., Kimoto M., Tsuji H., Reaven G.M., and Cooke J.P. Impaired nitric oxide synthase pathway in diabetes mellitus, role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106 (2002) 987-992
22. Loyaga-Rendon R.Y., Sakamoto S., Beppu M., Aso T., Ishizaka M., Takahashi R., and Azuma H. Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries. Atherosclerosis 178 (2005) 231-239
23. MacAllister R.J., Parry H., Kimoto M., Ogawa T., Russell R.J., Hodoson H., Whitley G.S., and Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 119 (1996) 1533-1540
24. Masuda H., Goto M., Tamaoki S., and Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. Br. J. Pharmacol. 126 (1999) 211-218
25. Masuda H., Tsujii T., Okuno T., Kihara K., Goto M., and Azuma H. Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired cavernosal relaxation with ischemia. Am. J. Physiol., Regul. Integr. Comp. Physiol. 282 (2002) R1730-R1738
26. McDonald K.K., Zharikov S., Block E.R., and Kilberg M.S. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric oxide synthase may explain the arginine paradox. J. Biol. Chem. 272 (1997) 31213-31216
27. Miller R.A., and Wilson R.B. Atherosclerosis and myocardial ischemic lesions in alloxan-diabetic rabbits fed a low cholesterol diet. Atherosclerosis 4 (2000) 586-591
28. Mori M., and Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem. Biophys. Res. Commun. 275 (2000) 715-719
29. Napoli C., and Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 5 (2001) 88-97
30. Niimi Y., Azuma H., and Hirakawa K. Repeated endothelial removal augments intimal thickening and attenuates EDRF release. Am. J. Physiol., Heart Circ. Physiol. 226 (1994) H1348-H1356
31. Obayashi S., Beppu M., Aso T., Goto M., and Azuma H. 17β-Estradiol increases nitric oxide and prostaglandin I2 production by cultured human uterine arteries only in histologically normal specimens. J. Cardiovasc. Pharmacol. 38 (2001) 240-249
32. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J. Biol. Chem. 264 (1989) 10205-10209
33. Surdacki A., Nowicki M., Sandmann J., Tsikas D., Boeger R.H., Bode-Boeger S.M., Kruszelnicka-Kwiatkowska O., Kokot F., Dubiel J.S., and Froelich J.C. Reduced urinary excretion of nitric oxide metabolites and increased plasma asymmetric dimethylarginine in men with essential hypertension. J. Cardiovasc. Pharmacol. 33 (1999) 652-658
34. Vallance P., Leone A.M., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 239 (1992) 572-575
35. Xu W., Kaneko F.T., Zheng S., Comhair S.A.A., Janocha A.J., Coggans T., Thunnissen F., Farver C., Hazen S.L., Jennings C., Dweik R.A., Arroliga A.C., and Erzurum S.C. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 18 (2004) 1746-1748 (Electronic publication)